AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 31 min read$MRSH

Doyle John Q sold $3.1M of MRSH

Doyle John Q (President and CEO) sold 16,656 shares of MARSH & MCLENNAN COMPANIES, INC. (MRSH) at $188.51 ($3.14M total) on 2026-09-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Doyle John Q
Published Sep 3, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 8:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$MRSH
Bearish
medium confidence
Mentioned
$MRSH
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRSHBearishLow
01

Why it matters

The disclosed sale may trigger sell pressure, especially if investors interpret it as a lack of confidence.

02

Market read

Insider sell by the CEO is a material event that could affect MRSH's stock price in the near term.

03

What to watch

Potential tax planning or portfolio rebalancing may drive the transaction.

Relevance 5/10Novelty 8/10Timing: post-market 2026-09-02

Background

Form 4 filings provide direct insight into insider transactions, often influencing short-term price action.

Company-level read

Ticker impact

$MRSHBearishMedium confidence
Context

CEO John Q. Doyle sold 16,656 shares for $3.14M via a 10b5-1 plan on 2026-09-02.

Expected impact

possible short-term downside pressure

Evidence & confidence

Large insider sell from top executive, disclosed in Form 4, often leads to negative market reaction.

Market effects

Sector

Minimal impact on insurance sector; may prompt scrutiny of executive confidence.

Regional

Limited to US markets where MRSH trades.

Global

Low

Counterpoint

What could challenge this read

The sale could be a routine 10b5-1 execution unrelated to company outlook.

Key entities

  • Company
    Marsh & McLennan Companies, Inc.

    Global professional services firm providing risk, strategy, and insurance solutions.

  • Executive
    John Q. Doyle

    President and CEO of Marsh & McLennan.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

MRSH insider trading history →

Related articles

OCT 15
$MRSHMedAI 8/10

Why Marsh (MRSH) Stock Is Trading Up Today

Marsh (MRSH) shares rose 4.7% after reporting Q3 2026 results with 8% revenue growth and 10% increase in adjusted EPS. GAAP earnings were $1.69, adjusted earnings $2.03. The company repurchased $500M in stock and raised its savings target to $600M. Shares closed at $186.43, up 4.5%.

finance.yahoo.com5 min
OCT 15
$MRSHHighAI 8/10

Marsh McLennan earnings analysis: questions answered and next catalysts

Marsh McLennan (MRSH) reported Q3 FY2026 earnings on Oct 15, 2026, beating estimates with EPS of $2.03 and revenue of $6.86B. The stock rose 5.49% to $188.19. Analysts had lowered price targets before the report, contributing to the rally. Key questions remain about organic growth durability and valuation. Next catalysts include Q4 earnings, 2027 guidance, and analyst revisions.

investing.com2 min
OCT 15
$MRSHHighAI 8/10

Marsh McLennan (MRSH) Q3 2026 Earnings Call Transcript

Marsh McLennan (MRSH) reported Q3 2026 earnings with revenue up 8%, adjusted operating income up 6%, and adjusted EPS up 10%. The company highlighted growth in consulting and risk services, increased Thrive savings target to $600M, and progress in AI integration. They also repurchased $500M in stock. Market conditions showed mixed rate changes across regions and lines of business.

finance.yahoo.com2 min